SEC 13F Intelligence

Dekabank Deutsche Girozentrale / BSX

Dekabank Deutsche Girozentrale’s Boston Scientific Corp Position

Does Dekabank Deutsche Girozentrale own Boston Scientific Corp (BSX)? Yes — 1.84M shares worth $118M (+0.19% of its 13F portfolio) as of Q1 2026.

Position Value
$118M
Q1 2026
Shares
1.84M
% of Portfolio
+0.19%
Quarters Held
28
currently held

Position History BSX

Reported value by quarter
Q1 ’19: $12MQ1 ’19Q2 ’19: $19MQ3 ’19: $15MQ4 ’19: $14MQ1 ’20: $14MQ1 ’20Q2 ’20: $10MQ3 ’20: $17MQ1 ’21: $22MQ2 ’21: $23MQ2 ’21Q3 ’21: $19MQ4 ’21: $22MQ1 ’22: $42MQ2 ’22: $31MQ2 ’22Q3 ’22: $26MQ4 ’22: $30MQ1 ’23: $32MQ2 ’23: $32MQ2 ’23Q3 ’23: $46MQ4 ’23: $88MQ1 ’24: $116MQ2 ’24: $154MQ2 ’24Q3 ’24: $155MQ4 ’24: $165MQ1 ’25: $165MQ2 ’25: $195MQ2 ’25Q3 ’25: $180MQ4 ’25: $146MQ1 ’26: $118Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.84M$118M+0.19%
Q4 20251.84M$146M+0.25%
Q3 20251.84M$180M+0.30%
Q2 20251.84M$195M+0.35%
Q1 20251.70M$165M+0.32%
Q4 20241.84M$165M+0.30%
Q3 20241.84M$155M+0.29%
Q2 20241.97M$154M+0.28%
Q1 20241.70M$116M+0.22%
Q4 20231.55M$88M+0.18%
Q3 2023862.7K$46M+0.11%
Q2 2023586.9K$32M+0.07%
Q1 2023647.8K$32M+0.08%
Q4 2022657.6K$30M+0.08%
Q3 2022670.5K$26M+0.08%
Q2 2022840.9K$31M+0.09%
Q1 2022938.0K$42M+0.10%
Q4 2021505.5K$22M+0.05%
Q3 2021437.6K$19M+0.05%
Q2 2021546.7K$23M+0.07%
Q1 2021575.0K$22M+0.07%
Q3 2020446.0K$17M+0.07%
Q2 2020289.7K$10M+0.06%
Q1 2020460.0K$14M+0.11%
Q4 2019303.1K$14M+0.08%
Q3 2019360.8K$15M+0.09%
Q2 2019443.3K$19M+0.09%
Q1 2019341.9K$12M+0.07%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Dekabank Deutsche Girozentrale’s full portfolio or all institutional holders of BSX.